These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Signal transduction activated by cannabinoid receptors. Díaz-Laviada I; Ruiz-Llorente L Mini Rev Med Chem; 2005 Jul; 5(7):619-30. PubMed ID: 16026308 [TBL] [Abstract][Full Text] [Related]
3. Cannabinoid receptors: where they are and what they do. Mackie K J Neuroendocrinol; 2008 May; 20 Suppl 1():10-4. PubMed ID: 18426493 [TBL] [Abstract][Full Text] [Related]
4. Activation of G-proteins in brain by endogenous and exogenous cannabinoids. Childers SR AAPS J; 2006 Mar; 8(1):E112-7. PubMed ID: 16584117 [TBL] [Abstract][Full Text] [Related]
5. The neurobiology and evolution of cannabinoid signalling. Elphick MR; Egertová M Philos Trans R Soc Lond B Biol Sci; 2001 Mar; 356(1407):381-408. PubMed ID: 11316486 [TBL] [Abstract][Full Text] [Related]
6. Cannabinoid signalling. Demuth DG; Molleman A Life Sci; 2006 Jan; 78(6):549-63. PubMed ID: 16109430 [TBL] [Abstract][Full Text] [Related]
7. Concomitant activation of adenylyl cyclase suppresses the opposite influences of CB(1) cannabinoid receptor agonists on tyrosine hydroxylase expression. Bosier B; Hermans E; Lambert DM Biochem Pharmacol; 2009 Jan; 77(2):216-27. PubMed ID: 18992715 [TBL] [Abstract][Full Text] [Related]
8. The endocannabinoid system: physiology and pharmacology. Rodríguez de Fonseca F; Del Arco I; Bermudez-Silva FJ; Bilbao A; Cippitelli A; Navarro M Alcohol Alcohol; 2005; 40(1):2-14. PubMed ID: 15550444 [TBL] [Abstract][Full Text] [Related]
9. CB receptor ligands from plants. Woelkart K; Salo-Ahen OM; Bauer R Curr Top Med Chem; 2008; 8(3):173-86. PubMed ID: 18289087 [TBL] [Abstract][Full Text] [Related]
10. CB(1) and CB(2) receptor-mediated signalling: a focus on endocannabinoids. McAllister SD; Glass M Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):161-71. PubMed ID: 12052033 [TBL] [Abstract][Full Text] [Related]
12. Cannabinoid receptor ligands as potential anticancer agents--high hopes for new therapies? Oesch S; Gertsch J J Pharm Pharmacol; 2009 Jul; 61(7):839-53. PubMed ID: 19589225 [TBL] [Abstract][Full Text] [Related]
13. Cannabinoid receptor ligands: clinical and neuropharmacological considerations, relevant to future drug discovery and development. Pertwee RG Expert Opin Investig Drugs; 2000 Jul; 9(7):1553-71. PubMed ID: 11060760 [TBL] [Abstract][Full Text] [Related]
14. Biased agonism at the cannabinoid receptors - Evidence from synthetic cannabinoid receptor agonists. Patel M; Finlay DB; Glass M Cell Signal; 2021 Feb; 78():109865. PubMed ID: 33259937 [TBL] [Abstract][Full Text] [Related]
15. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity? Nevalainen T; Irving AJ Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712 [TBL] [Abstract][Full Text] [Related]
16. Signaling pathways involved in the development of cannabinoid tolerance. Martin BR; Sim-Selley LJ; Selley DE Trends Pharmacol Sci; 2004 Jun; 25(6):325-30. PubMed ID: 15165748 [TBL] [Abstract][Full Text] [Related]
17. Cannabinoid receptors and their ligands. Pertwee RG; Ross RA Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):101-21. PubMed ID: 12052030 [TBL] [Abstract][Full Text] [Related]
18. Pharmacological selection of cannabinoid receptor effectors: Signalling, allosteric modulation and bias. Manning JJ; Green HM; Glass M; Finlay DB Neuropharmacology; 2021 Aug; 193():108611. PubMed ID: 34000272 [TBL] [Abstract][Full Text] [Related]
19. Cannabinoid receptors: nomenclature and pharmacological principles. Console-Bram L; Marcu J; Abood ME Prog Neuropsychopharmacol Biol Psychiatry; 2012 Jul; 38(1):4-15. PubMed ID: 22421596 [TBL] [Abstract][Full Text] [Related]
20. Cannabinoid/Endocannabinoid signaling impact on early pregnancy events. Sun X; Dey SK Curr Top Behav Neurosci; 2009; 1():255-73. PubMed ID: 21104387 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]